{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:32:45Z","timestamp":1794695565211,"version":"4.9.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.vaccine.2013.04.036","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T20:18:10Z","timestamp":1366921090000},"page":"2852-2861","source":"Crossref","is-referenced-by-count":95,"title":["Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine"],"prefix":"10.1016","volume":"31","author":[{"given":"Ouli","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnstein","family":"Norheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.04.036_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/317534","article-title":"Burden of meningitis and other severe bacterial infections of children in africa: implications for prevention","volume":"32","author":"Peltola","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0010","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0015","first-page":"47","article-title":"Sequelae due to bacterial meningitis among African children: a systematic literature review","volume":"7","author":"Ramakrishnan","year":"2009","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0035-9203(87)90397-X","article-title":"Mortality from meningococcal disease during an epidemic in The Gambia, West Africa","volume":"81","author":"Greenwood","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0035-9203(02)90089-1","article-title":"Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa","volume":"96","author":"Molesworth","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2013.04.036_bib0030","first-page":"1","article-title":"Cerebrospinal meningitis in AFRICA","volume":"28","author":"Lapeyssonnie","year":"1963","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(07)70288-8","article-title":"Meningococcal carriage in the African meningitis belt","volume":"7","author":"Trotter","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0050","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/infdis\/jir623","article-title":"Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity","volume":"204","author":"Mueller","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3201\/eid0910.030182","article-title":"Environmental risk and meningitis epidemics in Africa","volume":"9","author":"Molesworth","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0060","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/j.ijid.2009.08.013","article-title":"A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt","volume":"14","author":"Mueller","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0065","first-page":"57","article-title":"Meningitis in Chad, Niger and Nigeria: 2009 epidemic season","volume":"85","author":"World Health Organization","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0070","doi-asserted-by":"crossref","first-page":"e19513","DOI":"10.1371\/journal.pone.0019513","article-title":"Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso","volume":"6","author":"Delrieu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","author":"Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"April","key":"10.1016\/j.vaccine.2013.04.036_bib0080","article-title":"Description and nomenclature of Neisseria meningitidis capsule locus","author":"Harrison","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0085","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.trstmh.2006.03.002","article-title":"High sensitivity and specificity of the Pastorex latex agglutination test for Neisseria meningitidis serogroup A during a clinical trial in Niger","volume":"100","author":"Borel","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.04.036_bib0090","doi-asserted-by":"crossref","first-page":"A30","DOI":"10.1016\/j.vaccine.2007.04.037","article-title":"Biological diagnosis of meningococcal meningitis in the African meningitis belt: current epidemic strategy and new perspectives","volume":"25","author":"Chanteau","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0095","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/JCM.42.4.1764-1765.2004","article-title":"PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z","volume":"42","author":"Bennett","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/JCM.42.1.320-328.2004","article-title":"Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis","volume":"42","author":"Mothershed","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/507339","article-title":"The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002\u20132005","volume":"43","author":"Traore","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0110","doi-asserted-by":"crossref","first-page":"e11086","DOI":"10.1371\/journal.pone.0011086","article-title":"Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007","volume":"5","author":"Rose","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0115","doi-asserted-by":"crossref","first-page":"e7326","DOI":"10.1371\/journal.pone.0007326","article-title":"Field evaluation of two rapid diagnostic tests for Neisseria meningitidis serogroup A during the 2006 outbreak in Niger","volume":"4","author":"Rose","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0120","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/JCM.43.10.5129-5135.2005","article-title":"Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes","volume":"43","author":"Nicolas","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.04.036_bib0125","doi-asserted-by":"crossref","first-page":"B64","DOI":"10.1016\/j.vaccine.2009.04.061","article-title":"Meningococcal carriage and disease\u2014population biology and evolution","volume":"27","author":"Caugant","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0130","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1073\/pnas.061386098","article-title":"Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis","volume":"98","author":"Zhu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0135","doi-asserted-by":"crossref","first-page":"e46019","DOI":"10.1371\/journal.pone.0046019","article-title":"Molecular characterization of invasive meningococcal isolates from countries in the African Meningitis Belt before Introduction of a serogroup A conjugate vaccine","volume":"7","author":"Caugant","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0140","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pmed.0040101","article-title":"Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana","volume":"4","author":"Leimkugel","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0145","unstructured":"WHO Inter Country Support Team \u2013 West Africa. Meningitis Weekly Bulletin. Week 48\u201352 2011. Ouagadougou, Burkina Faso; January 2012."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","volume":"12","author":"Novak","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14760584.5.3.319","article-title":"Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines","volume":"5","author":"Mueller","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson Lecture. Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0165","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(75)92281-3","article-title":"Group-C meningococcal meningitis in the northern savanna of Africa","volume":"305","author":"Whittle","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0170","first-page":"325","article-title":"Epidemic group C meningococcal meningitis in Upper Volta, 1979","volume":"61","author":"Broome","year":"1983","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0175","first-page":"499","article-title":"Epidemiology of bacterial meningitis in Niamey, Niger, 1981\u201396","volume":"77","author":"Campagne","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0180","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1017\/S0950268806005929","article-title":"Evaluation of the meningitis epidemics risk model in Africa","volume":"134","author":"Savory","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02538460","article-title":"Serological typing of meningococci by means of micro-precipitation","volume":"27","author":"Slaterus","year":"1961","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JB.95.1.1-4.1968","article-title":"Serological studies of ungroupable Neisseria meningitidis","volume":"95","author":"Hollis","year":"1968","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0195","unstructured":"WHO Inter Country Support Team \u2013 West Africa. Meningitis Weekly Bulletin. Week 48\u201352 2010. Ouagadougou, Burkina Faso; January 2011."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0200","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1128\/IAI.71.12.6712-6720.2003","article-title":"Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-d-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X","volume":"71","author":"Tzeng","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/426436","article-title":"Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing","volume":"40","author":"Parent dC","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0210","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1128\/jb.169.6.2781-2792.1987","article-title":"Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern","volume":"169","author":"Caugant","year":"1987","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0215","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","article-title":"Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development","volume":"5","author":"Pajon","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0220","unstructured":"Jolley KA, Maiden MC. PubMLST database. Neisseria sequence type home page; 2013. www.pubmlst.org [accessed 13.03.13, Internet]."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0225","first-page":"181","article-title":"A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995","volume":"74","author":"Riou","year":"1996","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0230","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/JCM.32.9.2185-2191.1994","article-title":"Characterization of strains of Neisseria meningitidis recovered from complement-sufficient and complement-deficient patients in the Western Cape Province, South Africa","volume":"32","author":"Orren","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3201\/eid1302.051553","article-title":"Meningococcal disease in South Africa, 1999\u20132002","volume":"13","author":"Coulson","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0240","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/525260","article-title":"Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa","volume":"46","author":"von","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4269\/ajtmh.2009.80.619","article-title":"Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005\u20132006","volume":"80","author":"Mutonga","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0250","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-3156.2005.01394.x","article-title":"Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135","volume":"10","author":"Boisier","year":"2005","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0255","series-title":"Meningococcal meningitis serogroup X: a new player in Ugandan epidemiology","author":"Lewis","year":"2006"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0260","first-page":"227","article-title":"Epidemiological notes: meningococcal meningitis of serogroup X in Niamey (Niger)","volume":"50","author":"Etienne","year":"1990","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0265","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1360-2276.2003.01126.x","article-title":"Outbreaks of serogroup X meningococcal meningitis in Niger 1995\u20132000","volume":"8","author":"Djibo","year":"2003","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0270","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3201\/eid1306.070042","article-title":"Serogroup X in meningococcal disease, Western Kenya","volume":"13","author":"Materu","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0275","unstructured":"WHO Inter Country Support Team \u2013 West Africa. Meningitis Weekly Bulletin. Week 26 2012. Ouagadougou, Burkina Faso; July 2012."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0280","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1473-3099(06)70584-9","article-title":"No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales","volume":"6","author":"Trotter","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0285","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1016\/j.vaccine.2007.03.001","article-title":"Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005","volume":"25","author":"Alonso","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S0022172400063828","article-title":"Meningococcal disease in South Australia: incidence and serogroup distribution 1971-1980","volume":"90","author":"Hansman","year":"1983","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0295","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/00365540701299616","article-title":"Genotypic analysis of serogroups other than A, B or C of Neisseria meningitidis in China","volume":"39","author":"Yang","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0300","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00029330-200804010-00017","article-title":"A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China","volume":"121","author":"Chen","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0305","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2334-12-310","article-title":"An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0310","unstructured":"EU-IBIS Network. Invasive Neisseria meningitidis in Europe 2006. London: HealthProtection Agency; 2006. www.euibis.org [accessed 03.04.13, Internet]."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0315","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF01643964","article-title":"Meningococcal infections in the German Democratic Republic 1971\u20131984","volume":"14","author":"Grahlow","year":"1986","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0320","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3201\/eid1602.091553","article-title":"Neisseria meningitidis serogroup X sequence type 2888, Italy","volume":"16","author":"Fazio","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0325","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3201\/eid0805.010227","article-title":"Clonal groupings in serogroup X Neisseria meningitidis","volume":"8","author":"Gagneux","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0330","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1046\/j.1469-0691.2003.00685.x","article-title":"Infections by Neisseria meningitidis serogroup X in Spain","volume":"9","author":"del Castillo","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0335","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/clinids\/18.5.780","article-title":"Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria","volume":"18","author":"Fijen","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0340","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1128\/JCM.01417-10","article-title":"Neisseria meningitidis serogroup X sequence type 767 in Turkey","volume":"48","author":"Kilic","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0345","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00365540600904761","article-title":"Diagnosis of meningococcal meningitis in Brazil by use of PCR","volume":"39","author":"Pedro","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0350","first-page":"1173","article-title":"Severe meningococcal disease caused by serogroups X and Z","volume":"134","author":"Ryan","year":"1980","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0355","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0360","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1086\/339010","article-title":"Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana","volume":"185","author":"Gagneux","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0365","first-page":"363","article-title":"Pharyngeal carriage of Neisseria meningitidis in a school of Niamey, Niger","volume":"64","author":"Djibo","year":"2004","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0370","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3201\/eid1306.061395","article-title":"Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003","volume":"13","author":"Mueller","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0375","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/499822","article-title":"Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002","volume":"193","author":"Raghunathan","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0380","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CVI.00479-10","article-title":"Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine","volume":"18","author":"Kristiansen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0385","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/jmm.0.45529-0","article-title":"Neisseria meningitidis: an overview of the carriage state","volume":"53","author":"Yazdankhah","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0390","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/infdis\/jir466","article-title":"Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation","volume":"204","author":"Ibarz-Pavon","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0395","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1017\/S0950268811001865","article-title":"Distribution of serogroups and sequence types in disease-associated and carrier strains of Neisseria meningitidis isolated in China between 2003 and 2008","volume":"140","author":"Zhou","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0400","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.vaccine.2012.12.022","article-title":"Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?","volume":"31","author":"Hong","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0405","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0410","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1073\/pnas.1019751108","article-title":"Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination","volume":"108","author":"Budroni","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0415","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/IAI.6.5.773-778.1972","article-title":"Physicochemical properties of Neisseria meningitidis group X polysaccharide antigen","volume":"6","author":"Apicella","year":"1972","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0420","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1128\/iai.1.1.8-14.1970","article-title":"Isolation and Characterization of Neisseria meningitidis Groups A, C, X, and Y Polysaccharide Antigens","volume":"1","author":"Robinson","year":"1970","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0425","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0008-6215(00)85053-3","article-title":"An improved procedure for the isolation of meningococcal, polysaccharide antigens, and the structural determination of the antigen from serogroup X","volume":"26","author":"Bundle","year":"1973","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0430","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1016\/S0021-9258(19)42390-9","article-title":"Studies on the group-specific polysaccharide of Neisseria meningitidis serogroup X and an improved procedure for its isolation","volume":"249","author":"Bundle","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0435","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0021-9258(19)42828-7","article-title":"Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. Studies on the group-specific antigens of Neisseria meningitidis serogroups A and X","volume":"249","author":"Bundle","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0440","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1016\/j.vaccine.2012.07.032","article-title":"Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies","volume":"30","author":"Xie","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0445","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jpba.2012.07.014","article-title":"Quantitative Proton Nuclear Magnetic Resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X","volume":"70","author":"Garrida","year":"2012","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0450","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1016\/j.vaccine.2012.08.021","article-title":"Relative stability of meningococcal serogroup A and X polysaccharides","volume":"30","author":"Berti","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0455","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1002\/chem.200601743","article-title":"Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A","volume":"13","author":"Torres-Sanchez","year":"2007","journal-title":"Chemistry"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0460","unstructured":"Vann WF. The Neisseria meningitidis serogroup X xcbA gene product catalyses synthesis of the bacterial capsular polysaccharide. 26th International Carbohydrate Symposium (ICS2012). 22.07.2012. Madrid, Spain. 2012, P250."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0465","unstructured":"Gerardy-Schahn R, M\u00fchlanhoff M, Bethe A, Stummeyer K, Freiberger F, Damerow S, inventors. Means and methods for producing artificial capsular polysaccharides of Neisseria meningitidis. U.S. patent application mumber US2013\/0012471 A1. Issued 10.01.2013."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0470","first-page":"166","article-title":"Synthesis of Neisseria meningitidis X capsular polysaccharide","volume":"ii","author":"Morelli","year":"2013","journal-title":"Arch Org Chem"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0475","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1574-695X.2000.tb01475.x","article-title":"Prevalence of de-O-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom","volume":"28","author":"Borrow","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0480","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1574-695X.2002.tb00543.x","article-title":"O-Acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK","volume":"32","author":"Longworth","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0485","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1074\/jbc.M807518200","article-title":"The polysialic acid-specific O-acetyltransferase OatC from Neisseria meningitidis serogroup C evolved apart from other bacterial sialate O-acetyltransferases","volume":"284","author":"Bergfeld","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0490","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/IAI.70.7.3707-3713.2002","article-title":"Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses","volume":"70","author":"Berry","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0495","first-page":"151","article-title":"Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope","volume":"103","author":"Michon","year":"2000","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0500","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0505","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/infdis\/135.1.94","article-title":"Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92","volume":"135","author":"Glode","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0510","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/IAI.13.6.1654-1662.1976","article-title":"Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide","volume":"13","author":"Vann","year":"1976","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0515","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/515622","article-title":"Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization","volume":"178","author":"Jones","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0520","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/137.2.112","article-title":"Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children","volume":"137","author":"Gold","year":"1978","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.04.036_bib0525","doi-asserted-by":"crossref","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0530","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.carres.2006.10.006","article-title":"Natural phosphoglycans containing glycosyl phosphate units: structural diversity and chemical synthesis","volume":"342","author":"Nikolaev","year":"2007","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0535","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj1300681","article-title":"A polymer of N-acetylglucosamine 1-phosphate in the wall of Staphylococcus lactis 2102","volume":"130","author":"Archibald","year":"1972","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0540","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01093-09","article-title":"Synthetic {beta}-(1\u21926)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens","volume":"78","author":"Gening","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0545","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2010.04.112","article-title":"Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method","volume":"28","author":"Chen","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0550","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0555","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/171.1.93","article-title":"The impact of conjugate vaccine on carriage of Haemophilus influenzae type b","volume":"171","author":"Barbour","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0560","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0565","unstructured":"Romano MR, Micoli F, Balducci E, et al. Development of a serogroup X meningococcal conjugate vaccine. XVIIIth International Pathogenic Neisseria Conference 09.09.2012. W\u00fcrzburg, Germany."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0570","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1473-3099(09)70324-X","article-title":"Serogroup B meningococcal vaccines-an unfinished story","volume":"10","author":"Sadarangani","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0575","doi-asserted-by":"crossref","unstructured":"Norheim G, Tunheim G, Naess LM, et al. A trivalent outer membrane vesicle (OMV) vaccine against serogroup A, W-135 and X meningococcal disease. XVIIIth International Pathogenic Neisseria Conference 09.09.2012. W\u00fcrzburg, Germany.","DOI":"10.1111\/j.1365-3083.2012.02709.x"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0580","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0585","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2011.11.084","article-title":"Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide","volume":"30","author":"Zollinger","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0590","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1128\/CVI.00070-12","article-title":"Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine","volume":"19","author":"Moran","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0595","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1016\/j.vaccine.2007.01.022","article-title":"Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease","volume":"25","author":"Nokleby","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0600","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(99)03366-8","article-title":"Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa","volume":"355","author":"Woods","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.04.036_bib0605","unstructured":"World Health Organization and Centers for Disease Control and Prevention. Technical Guidelines for Integrated Disease Surveillance and Response in the African Region, Brazzaville, Republic of Congo and Atlanta, USA; 2010. p. 1\u2013398."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0610","unstructured":"World Health Organization. Managing meningitis epidemics in Africa. A quick reference guide for health authorities and health-care workers, second edition. Geneva, Switzerland: WHO\/HSE\/GAR\/ERI\/2010.4; November 2010."},{"key":"10.1016\/j.vaccine.2013.04.036_bib0615","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/AAC.00994-08","article-title":"Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives","volume":"53","author":"Hedberg","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T20:24:00Z","timestamp":1644870240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13004751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":123,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0264410X13004751"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}